Cellular Dynamics International (CDI) announced today the appointment of Leroy Hood, M.D., Ph.D., and George Church, Ph.D., two of the world's leading scientists in molecular biotechnology and genomics, to the company's scientific advisory board. Hood and Church join stem cell pioneer James Thomson, V.M.D.,...
OnBioVC.com recently reported on the trends of international VC bioscience funding for the 2Q 2009 and found that there were 88 financings for 2Q09 versus 71 deals in 2Q08. The combined second quarter 2009 bioscience investment totaled approximately $1.7B, an increase of roughly $538.2M compared...
The Pharmaceutical Drug industry usually has high visibility with consumers in overall healthcare costs although it only represents some 10% of total U.S. healthcare expense to the consumer. The worldwide, and in particular U.S. drug industry sales, have slowed considerably due to an overall slowdown...
Lilly Ventures, the venture capital arm of Eli Lilly & Co., has spun out from its parent in an effort to compensate its members more like a traditional venture firm. As part of the spinout, completed May 1, Lilly Ventures secured $200 million from its corporate...
Researchers at the University of Florida claim to be the first to use targeted gene manipulation to take adult stem cells and change them into another kind of cell completely. They changed the stem cells, from bone marrow in this instance, into retinal cells. These...
Promega Corporation has purchased Turner BioSystems Inc. to grow their mutual interest in offering high quality integrated systems (optimized instrument with reagents) to life scientists in research, drug discovery and clinical diagnostics. The companies are continuing their established partnership for integrated bioluminescent technologies. They...
MADISON - Exact Sciences Corp. today announced the appointment of Graham P. Lidgard, Ph.D., as the company’s chief scientific officer. Dr. Lidgard, 60, brings more than three decades of clinical diagnostics experience to Exact. His past work includes molecular and immunoassay diagnostic product...
The benefits of the Small Business Innovation Research (SBIR) program have been measured and reviewed in detail by many organizations, including the National Academy of Sciences. The program is generally credited with significant innovation, resulting in benefits such as patents, jobs and commercialized products. Reauthorization...
The University of Wisconsin-Madison's nearly $840 million research portfolio, one of the top three in the country, will become even larger as federal agencies begin to dole out new stimulus grants. Already, 90 awards totaling more than $26.5 million have been made to UW-Madison faculty under...
The second quarter brought some good news for U.S. venture capital and companies: investment was up for the quarter by 15% over the first quarter with the dollar investment level up 15% ($3.7 billion versus $3.2 billion), and the actual number of deals completed ...